Masimo, Inc.
Irvine, CA 92614
Share:
Masimo Announces Continuous Noninvasive Total Hemoglobin
Masimo to debut this latest Rainbow SETÃ-® parameter at the upcoming World Congress of Anesthesiologists Meeting IRVINE, Calif., Feb. 25 -- Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced that it will debut its breakthrough technology for noninvasive and continuous total hemoglobin (SpHb(TM)) and oxygen content (SpOC(TM))...
Read More »New Study Shows that Masimo SET Pulse Oximetry May be a Valuable Clinical Tool for Diagnosis of Congenital Heart Disease in Newborns
New Low Cost Method for Detecting Heart Defects in Newborns Could Save Many Lives IRVINE, Calif., Feb. 22 // -- Masimo, the inventor and leader of Pulse CO-Oximetry and read-though motion and low perfusion pulse oximetry, announced that a recent study, published in Acta Peadiatrica, shows that Masimo SET pulse oximetry is effective in detecting duct dependent congenital heart disease in infants....
Read More »Masimo to Present at the Cowen and Company Health Care Conference
IRVINE, Calif., Feb. 22, 2011 - Masimo (Nasdaq: MASI) today announced that its management is scheduled to present at the Cowen and Company Health Care Conference at The Marriott Copley Place in Boston on Tuesday, March 8, 2011, at 8:45 a.m. E.T. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the...
Read More »Masimo to Present at 29th Annual J.P. Morgan Healthcare Conference
IRVINE, Calif., Dec. 23, 2010 - Masimo (Nasdaq: MASI) today announced that its management is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Tuesday, January 11, 2011, at 11:30 a.m. PT. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be...
Read More »Masimo Announces Continuous Noninvasive Total Hemoglobin
Masimo to debut this latest Rainbow SETÃ-® parameter at the upcoming World Congress of Anesthesiologists Meeting IRVINE, Calif., Feb. 25 -- Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced that it will debut its breakthrough technology for noninvasive and continuous total hemoglobin (SpHb(TM)) and oxygen content (SpOC(TM))...
Read More »New Study Shows that Masimo SET Pulse Oximetry May be a Valuable Clinical Tool for Diagnosis of Congenital Heart Disease in Newborns
New Low Cost Method for Detecting Heart Defects in Newborns Could Save Many Lives IRVINE, Calif., Feb. 22 // -- Masimo, the inventor and leader of Pulse CO-Oximetry and read-though motion and low perfusion pulse oximetry, announced that a recent study, published in Acta Peadiatrica, shows that Masimo SET pulse oximetry is effective in detecting duct dependent congenital heart disease in infants....
Read More »